New users of antipsychotic medications among children enrolled in TennCare.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives of Pediatrics & Adolescent Medicine

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHPEDI.158.8.753PMID 15289247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antipsychotic-induced hyperprolactinaemia in women : pathophysiology , severity and consequences Selective literature review

  2003cited by this paper
• Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences

  2003cited by this paper
• A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States.

  2003cited by this paper
• Medicaid and mental health: be careful what you ask for.

  2003cited by this paper
• Treatment of aggression in children and adolescents with autism and conduct disorder.

  2003cited by this paper
• Psychotropic practice patterns for youth: a 10-year perspective.

  2003cited by this paper
• Concomitant psychotropic medication for youths.

  2003cited by this paper
• Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.

  2003cited by this paper
• Ziprasidone-associated galactorrhea in a female teenager.

  2003cited by this paper
• Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.

  2003cited by this paper
• Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.

  2002cited by this paper
• Risperidone in children with autism and serious behavioral problems.

  2002cited by this paper
• Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

  2002cited by this paper
• Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.

  2002cited by this paper
• Open trial of risperidone in 24 young children with pervasive developmental disorders.

  2001cited by this paper
• Risperidone in the Treatment of Behavioral Disturbances in Children and Adolescents with Borderline Intellectual Functioning: A Double-Blind, Placebo-Controlled Pilot Trial

  2001cited by this paper
• Psychopharmacology for young children: clinical needs and research opportunities.

  2001cited by this paper
• A novel augmentation strategy for treating resistant major depression.

  2001cited by this paper
• Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

  2001cited by this paper
• Trends in the prescribing of psychotropic medications to preschoolers.

  2000cited by this paper
• Antipsychotics in children and adolescents.

  1999influential reference
• Changes in continuity of enrollment among high-risk children following implementation of TennCare.

  1999cited by this paper
• Tennessee's failed managed care program for mental health and substance abuse services.

  1998cited by this paper
• Prevalence and Patterns of Psychotropic and Anticonvulsant Medication Use in Children and Adolescents Referred to Residential Treatment

  1998cited by this paper
• Assessment and Management of Antipsychotic-Induced Adverse Events

  1998cited by this paper
• A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

  1998cited by this paper
• AACAP Official Action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD.

  1997cited by this paper
• Recall accuracy for prescription medications: self-report compared with database information.

  1995cited by this paper
• Comparing Sources of Drug Data about the Elderly

  1991cited by this paper
• Use of automated databases for pharmacoepidemiology research.

  1990cited by this paper
• Use of Medicaid data for pharmacoepidemiology.

  1989cited by this paper
• Analysis of covariance and standardization as instances of prediction.

  1982cited by this paper
• A Comparison of Patient Drug Regimens as Viewed by the Physician, Pharmacist and Patient

  1981cited by this paper

• Predicting antipsychotic use in children.

  2025cites this paper
• Off-label second generation antipsychotics for impulse regulation disorders: a review.

  2025cites this paper
• Early-life risperidone alters locomotor responses to apomorphine and quinpirole in adulthood.

  2024cites this paper
• Prevalence of contraindicated combinations amid behavioral and mental health medications filled in a pediatric population

  2024cites this paper
• Antipsychotic Medications and Mortality in Children and Young Adults.

  2023cites this paper
• Narrative review of the advances in the pharmacotherapeutic management of juvenile-onset schizophrenia

  2023cites this paper
• Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016

  2021cites this paper
• The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children

  2021cites this paper
• Psychopharmaceutical Prescription Monitoring for Children in the Child Welfare System.

  2021cites this paper
• Trends in Antipsychotic Medication Use in Young Privately Insured Children.

  2020cites this paper
• Depression, Diabetes-Related Distress, and Anxiety in Pediatric Diabetes

  2020cites this paper
• New Users of Antipsychotics Among Children and Adolescents in 2008–2017: A Nationwide Register Study

  2020influential citation
• Follow-up Visit for Children and Adolescents on Antipsychotics Section 1 . Basic Measure Information 1

  2019cites this paper
• Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths

  2019cites this paper
• Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD

  2019cites this paper
• Addressing Early Childhood Emotional and Behavioral Problems

  2019cites this paper
• Psychotropic medication use in children and adolescents: review of outpatient treatments

  2018cites this paper
• Dosing and Monitoring: Children and Adolescents.

  2018cites this paper
• An Evaluation of Atypical Antipsychotic Use, Costs and Effectiveness in the Pediatric Population

  2018influential citation
• Prescribing Trends of Atypical Antipsychotic Drugs in an Outpatient Unit of a Child and Adolescent Clinic in Turkey

  2018cites this paper
• Concomitant Use of Psychotropic Medication With Stimulants for the Treatment of ADHD in Children and Adolescents: A Retrospective Insurance Claims Study in the United States

  2018cites this paper
• Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study.

  2018cites this paper
• Characteristics of Children Prescribed Antipsychotics: Analysis of Routinely Collected Data

  2018cites this paper
• Antipsychotic Polypharmacy among Children and Young Adults in Office-Based or Hospital Outpatient Department Settings

  2017cites this paper
• Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression Analyses.

  2017cites this paper
• Effect of Anti-Psychotic Drugs on Lipid and Prolactin Level among Sudanese patients

  2017cites this paper
• Pediatric Antipsychotic Use and Outcomes Monitoring

  2017cites this paper
• Factors Associated with Management of Teen Aggression: Child Psychiatric Clinical Decision Making

  2017influential citation
• Early‐life risperidone enhances locomotor responses to amphetamine during adulthood

  2017cites this paper
• Fostering Psychotropic Medication Oversight for Children in Foster Care: A National Examination of States’ Monitoring Mechanisms

  2017influential citation
• Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis.

  2016cites this paper
• Rodent Model as Tools in Ethical Biomedical Research

  2016cites this paper
• Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population

  2016cites this paper
• Trends in the use of antipsychotics in the Israeli inpatient population, 2004–2013

  2016influential citation
• Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis.

  2016cites this paper
• Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens

  2016cites this paper
• Patterns of Physician Antipsychotic Prescribing to Young Children

  2016cites this paper
• Addressing Early Childhood Emotional and Behavioral Problems

  2016cites this paper
• Clinicians' experience of diagnosing children with oppositional defiant disorder (ODD) and pediatric bipolar disorder (PBD)

  2016cites this paper
• Assessment of Motor Function in Rodents: Behavioral Models Sharing Simplicity and Multifaceted Applicability

  2016cites this paper
• Addressing Early Childhood Emotional and Behavioral Problems

  2016cites this paper
• Patterns of Antipsychotic Prescribing by Physicians to Young Children.

  2016cites this paper
• Serotonergic antidepressant use and the risk of fracture: a population-based nested case–control study

  2015cites this paper
• Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents

  2015influential citation
• Rationale and Considerations for the Internet-Based Delivery of Parent-Child Interaction Therapy.

  2015cites this paper
• Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013

  2015cites this paper
• System struggles and substitutes: A qualitative study of general practitioner and psychiatrist experiences of prescribing antipsychotics to children and adolescents

  2015cites this paper
• Antipsychotic Use and Foster Care Placement Stability Among Youth With Attention-Deficit Hyperactivity/ Disruptive Behavior Disorders

  2015influential citation
• Using marginal structural models to identify the cardiovascular adverse effects of second generation antipsychotics in children and adolescents

  2015cites this paper
• Psychosocial Interventions for Child Disruptive Behaviors: A Meta-analysis

  2015cites this paper
• Comparison of Glycemic and Metabolic Control in Youth With Type 1 Diabetes With and Without Antipsychotic Medication: Analysis From the Nationwide German/Austrian Diabetes Survey (DPV)

  2015cites this paper
• Trends in Atypical Antipsychotics Prescribed to Children Six Years of Age or Less on Medicaid in Kentucky

  2015cites this paper
• Psychotropic prescribing patterns among adolescents in Northern Ireland presenting with psychotic symptoms during a 5-year period

  2015cites this paper
• Concurrent use of stimulants and second-generation antipsychotics among children with ADHD enrolled in Medicaid.

  2015cites this paper
• Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.

  2015cites this paper
• Antipsychotic Prescriptions for Children Aged 5 Years or Younger

  2014cites this paper
• Atypical Antipsychotic Use Among Medicaid-Insured Children and Adolescents: Duration, Safety, and Monitoring Implications

  2014cites this paper
• Period Prevalence of Concomitant Psychotropic Medication Usage Among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder During 2009

  2014influential citation
• Trends in Psychotropic Medication Use for Medicaid-Enrolled Preschool Children

  2014cites this paper
• Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.

  2014cites this paper
• Small Geographic Area Variations in Prescription Drug Use

  2014cites this paper
• Increasing use of atypical antipsychotics and anticonvulsants during pregnancy

  2013cites this paper
• Antipsychotic Treatment Patterns and Aggressive Behavior Among Adolescents in Residential Facilities

  2013cites this paper
• Evidence review and clinical guidance for the use of ziprasidone in Canada

  2013cites this paper
• Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study

  2013cites this paper
• Prevalence Of Anti-Diabetic And Antilipidemic Medications In Children And Adolescents Treated With Atypical Antipsychotics In A Virginia Medicaid Population

  2013cites this paper
• Rights and great responsibilities of academic pediatricians.

  2013cites this paper
• A+KIDS, a web-based antipsychotic registry for North Carolina youths: an alternative to prior authorization.

  2013cites this paper
• El DSM como mecanismo de psicopatologización y regulación social: el caso de los niños/as en Puerto Rico

  2013cites this paper
• Trends in Psychotropic Medication Use for Medicaid-Enrolled Preschool Children

  2013influential citation
• Pharmacoepidemiology of Antipsychotic Use in Youth with ADHD: Trends and Clinical Implications

  2013cites this paper
• Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.

  2013cites this paper
• Efficacy of risperidone in children with disruptive behavioural disorders

  2013cites this paper
• Polypharmacy Reduction in Youth in a Residential Treatment Center Leads to Positive Treatment Outcomes and Significant Cost Savings

  2013cites this paper
• Antipsychotic and Psychostimulant Drug Combination Therapy in Attention Deficit/Hyperactivity and Disruptive Behavior Disorders: A Systematic Review of Efficacy and Tolerability

  2013cites this paper
• A Population-Based Study of Antipsychotic Prescription Trends in Children and Adolescents in British Columbia, from 1996 to 2011

  2013cites this paper
• Effectiveness and Tolerability of Aripiprazole in a Real-World Outpatient Population of Youth

  2012cites this paper
• Could treatment of iron deficiency both improve ADHD and reduce cardiovascular risk during treatment with ADHD drugs?

  2012cites this paper
• Secondary effects of antipsychotic treatment in naive or quasi-naive children and adolescents: design of a follow-up protocol and baseline results.

  2012cites this paper
• A Review of Pharmacoepidemiologic Studies of Antipsychotic Use in Children and Adolescents

  2012cites this paper
• Treatment of Maladaptive Aggression in Youth: CERT Guidelines II. Treatments and Ongoing Management

  2012cites this paper
• Treatment of Maladaptive Aggression in Youth: CERT Guidelines I. Engagement, Assessment, and Management

  2012cites this paper
• Adverse Effects and Toxicity of the Atypical Antipsychotics: What is Important for the Pediatric Emergency Medicine Practitioner.

  2012cites this paper
• Persistence of Stimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

  2012cites this paper
• Psychotropic drug and polypharmacy use among adolescents and young adults: Findings from the Finnish 1981 Nationwide Birth Cohort Study

  2012cites this paper
• Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.

  2012cites this paper
• Concurrent Stimulant and Atypical Antipsychotic Drug Use in Children and Adolescents Diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD) DISSERTATION

  2012cites this paper
• Pharmacoepidemiology of Psychotropic Medications in Youth

  2012cites this paper
• ÇOCUK VE ERGEN PSİKİYATRİSİ POLİKLİNİĞİNE BAŞVURAN HASTALARA TEDAVİ UYGULAMALARI TREATMENT APPROACHES IN A CHILD AND ADOLESCENT PSYCHIATRIC OUTPATIENT CLINIC

  2012cites this paper
• Antidepressant treatment of Medicaid‐insured youth with a cancer diagnosis

  2012cites this paper
• Examining The Effect Of Fda Approval Of Risperdal For Pediatric Use On Prescribing Trends From 2005-2008

  2012cites this paper
• Psychopharmacology in Preschool Children

  2012cites this paper
• Psychotropic Medication Use in Older Foster Youth: A Focus on Racial Differences

  2012cites this paper
• Secondary effects of antipsychotic treatment in naive or quasi-naive children and adolescents: design of a follow-up protocol and baseline results.

  2012cites this paper
• Antipsychotic Medication Use Among Children and Risk of Diabetes Mellitus

  2011cites this paper
• Early Diagnoses and Psychotherapeutic Medication Treatment Experiences of a Cohort of Children Under 6 Years Old Who Received Antipsychotic Treatment in Florida's Medicaid Program

  2011cites this paper
• PSYCHOTROPIC PRESCRIBING PATTERNS AMONG ADOLESCENTS IN NORTHERN IRELAND PRESENTING WITH PSYCHOTIC SYMPTOMS DURING A FIVE YEAR PERIOD

  2011cites this paper
• Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.

  2011cites this paper
• Adverse effects of oral nonstimulant psychotropic medications in young children reported to a regional poison center

  2011cites this paper
• Psychotropic Drug Use among Children: A Comparison of ADHD Drug Use in the Nordic Countries and the Effect of ADHD Drug Treatment on Academic Progress

  2011cites this paper